Daewon Pharmaceutical Co., Ltd (003220) Ratios

― Followers

Daewon Pharmaceutical Co., Ltd Ratios

KR:003220's free cash flow for Q2 2026 was ₩0.45. For the 2026 fiscal year, KR:003220's free cash flow was decreased by ₩ and operating cash flow was ₩<0.01. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.12	1.19	1.28	1.15	1.62
Quick Ratio	0.62	0.73	0.72	0.57	0.90
Cash Ratio	0.11	0.22	0.08	0.16	0.21
Solvency Ratio	0.09	0.07	0.11	0.17	0.25
Operating Cash Flow Ratio	0.12	0.20	0.15	0.28	0.26
Short-Term Operating Cash Flow Coverage	0.20	0.38	0.25	0.47	0.54
Net Current Asset Value	₩ -64.04B	₩ -78.61B	₩ -41.24B	₩ -34.44B	₩ 2.50B
Leverage Ratios
Debt-to-Assets Ratio	0.33	0.30	0.32	0.29	0.26
Debt-to-Equity Ratio	0.71	0.70	0.68	0.55	0.46
Debt-to-Capital Ratio	0.41	0.41	0.40	0.35	0.32
Long-Term Debt-to-Capital Ratio	0.18	0.20	0.19	0.11	0.17
Financial Leverage Ratio	2.14	2.31	2.12	1.91	1.81
Debt Service Coverage Ratio	-0.36	0.18	0.31	0.40	0.82
Interest Coverage Ratio	>-0.01	0.48	3.03	6.99	11.68
Debt to Market Cap	1.10	0.71	0.60	0.43	0.29
Interest Debt Per Share	9.14K	9.06K	9.23K	7.18K	5.68K
Net Debt to EBITDA	-4.04	5.14	3.74	2.42	1.45
Profitability Margins
Gross Profit Margin	44.88%	43.94%	48.04%	48.25%	49.69%
EBIT Margin	-10.66%	0.58%	4.26%	5.78%	8.85%
EBITDA Margin	-6.66%	4.50%	7.62%	9.11%	12.90%
Operating Profit Margin	-0.01%	0.58%	4.72%	6.12%	8.98%
Pretax Profit Margin	1.47%	0.45%	2.54%	4.90%	8.09%
Net Profit Margin	0.43%	-0.23%	2.38%	4.54%	6.67%
Continuous Operations Profit Margin	0.37%	-0.33%	1.69%	4.45%	6.40%
Net Income Per EBT	29.08%	-50.16%	93.53%	92.59%	82.50%
EBT Per EBIT	-13565.69%	78.93%	53.84%	80.14%	90.04%
Return on Assets (ROA)	0.46%	-0.22%	2.44%	4.71%	7.04%
Return on Equity (ROE)	1.00%	-0.52%	5.16%	8.98%	12.73%
Return on Capital Employed (ROCE)	-0.02%	0.88%	7.38%	9.91%	13.22%
Return on Invested Capital (ROIC)	>-0.01%	-0.49%	3.37%	6.72%	8.76%
Return on Tangible Assets	0.52%	-0.25%	2.69%	5.13%	7.73%
Earnings Yield	1.56%	-0.54%	4.68%	7.18%	8.10%
Efficiency Ratios
Receivables Turnover	10.56	7.53	7.68	7.46	7.16
Payables Turnover	16.16	11.21	14.86	13.04	12.30
Inventory Turnover	3.22	3.47	2.75	2.60	2.62
Fixed Asset Turnover	2.79	2.72	2.87	3.29	3.01
Asset Turnover	1.07	0.99	1.03	1.04	1.06
Working Capital Turnover Ratio	19.60	12.48	14.34	9.97	6.08
Cash Conversion Cycle	125.27	121.14	155.85	161.55	160.43
Days of Sales Outstanding	34.55	48.48	47.52	48.90	50.96
Days of Inventory Outstanding	113.31	105.23	132.89	140.63	139.14
Days of Payables Outstanding	22.59	32.57	24.56	27.99	29.67
Operating Cycle	147.87	153.71	180.41	189.54	190.09
Cash Flow Ratios
Operating Cash Flow Per Share	1.17K	2.03K	1.41K	2.47K	1.58K
Free Cash Flow Per Share	94.43	642.65	-1.11K	1.48K	943.39
CapEx Per Share	1.08K	1.39K	2.52K	982.33	631.66
Free Cash Flow to Operating Cash Flow	0.08	0.32	-0.78	0.60	0.60
Dividend Paid and CapEx Coverage Ratio	0.88	1.20	0.50	1.85	1.91
Capital Expenditure Coverage Ratio	1.09	1.46	0.56	2.51	2.49
Operating Cash Flow Coverage Ratio	0.13	0.23	0.16	0.35	0.29
Operating Cash Flow to Sales Ratio	0.04	0.07	0.05	0.10	0.07
Free Cash Flow Yield	1.20%	5.38%	-7.76%	9.34%	5.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	64.37	-185.65	21.40	13.93	12.35
Price-to-Sales (P/S) Ratio	0.28	0.42	0.51	0.63	0.82
Price-to-Book (P/B) Ratio	0.63	0.96	1.10	1.25	1.57
Price-to-Free Cash Flow (P/FCF) Ratio	83.55	18.59	-12.88	10.71	19.77
Price-to-Operating Cash Flow Ratio	6.72	5.88	10.10	6.44	11.84
Price-to-Earnings Growth (PEG) Ratio	0.06	1.69	-0.51	-0.57	0.03
Price-to-Fair Value	0.63	0.96	1.10	1.25	1.57
Enterprise Value Multiple	-8.17	14.55	10.39	9.36	7.84
Enterprise Value	334.53B	396.18B	473.57B	449.25B	484.12B
EV to EBITDA	-8.17	14.55	10.39	9.36	7.84
EV to Sales	0.54	0.65	0.79	0.85	1.01
EV to Free Cash Flow	165.28	28.74	-20.11	14.43	24.25
EV to Operating Cash Flow	13.30	9.09	15.77	8.68	14.53
Tangible Book Value Per Share	9.81K	10.07K	10.79K	10.62K	9.86K
Shareholders’ Equity Per Share	12.49K	12.40K	12.93K	12.69K	11.86K
Tax and Other Ratios
Effective Tax Rate	0.75	1.73	0.40	0.09	0.21
Revenue Per Share	28.69K	28.24K	28.10K	25.12K	22.63K
Net Income Per Share	122.80	-64.33	667.43	1.14K	1.51K
Tax Burden	0.29	-0.50	0.94	0.93	0.82
Interest Burden	-0.14	0.79	0.60	0.85	0.91
Research & Development to Revenue	0.04	0.04	0.04	0.03	0.04
SG&A to Revenue	0.22	0.20	0.20	0.18	0.21
Stock-Based Compensation to Revenue	0.00	0.00	0.00	0.00	0.00
Income Quality	6.35	101.62	3.32	2.16	1.09

Currency in KRW